|
Responding neurosurgeon’s specialty
|
|
Cerebrovascular
|
9 (6.3)
|
|
General
|
28 (19.5)
|
|
Functional
|
5 (3.5)
|
|
Multi-specialty
|
20 (13.9)
|
|
Neuro-oncology
|
75 (52.1)
|
|
Pediatric
|
3 (2.1)
|
|
Skull base
|
1 (0.7)
|
|
Spine
|
3 (2.1)
|
|
First diagnosis of COVID-19 in respondents’ region
|
|
December, 2019
|
8 (5.6)
|
|
January, 2020
|
97 (67.4)
|
|
February, 2020
|
33 (22.9)
|
|
March, 2020
|
4 (2.8)
|
|
Current number of COVID-19 cases in respondents’ region
|
|
< 100
|
5 (3.5%)
|
|
101–500
|
1 (0.7%)
|
|
501–1000
|
3 (2.1%)
|
|
> 1000
|
135 (93.8%)
|
|
Current number of COVID-19-related deaths in respondents’ region
|
|
< 100
|
0 (0%)
|
|
101–500
|
13 (9%)
|
|
501–1000
|
0 (%)
|
|
> 1000
|
137 (91%)
|
|
Public health restrictions in place
|
144 (100%)
|
|
Nature of public health restrictions
|
|
Restrictions on public gatherings of > 100 people
|
1 (0.7)
|
|
Restrictions on public gatherings of > 10 people
|
7 (4.9)
|
|
Restrictions on all public gatherings of any size
|
81 (56.3)
|
|
Complete curfew/blockade, closed nonessential services
|
54 (37.5)
|
|
Hospital is a COVID-19 dedicated hospital
|
73 (50.7)
|
|
COVID-19 patients have been hospitalized at hospital
|
95 (66.0)
|
|
Number of COVID-19-related hospitalizations at hospital
|
|
< 10
|
97 (67.4)
|
|
11–50
|
26 (18.1)
|
|
51–100
|
6 (4.2)
|
|
> 100
|
15 (10.4)
|
|
Percentage of COVID-19-patients by hospital capacity
|
|
< 10%
|
130 (95.0)
|
|
10–50%
|
6 (4.3)
|
|
> 50%
|
1 (0.7)
|
